- Home
- PNTG vs PRTA Comparison
PNTG vs PRTA Comparison
Compare PNTG & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNTG
- PRTA
- Stock Information
- Founded
- PNTG 2019
- PRTA 2012
- Country
- PNTG United States
- PRTA Ireland
- Employees
- PNTG N/A
- PRTA N/A
- Industry
- PNTG Medical/Nursing Services
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- PNTG Health Care
- PRTA Health Care
- Exchange
- PNTG Nasdaq
- PRTA Nasdaq
- Market Cap
- PNTG 805.7M
- PRTA 809.8M
- IPO Year
- PNTG N/A
- PRTA N/A
- Fundamental
- Price
- PNTG $26.18
- PRTA $6.58
- Analyst Decision
- PNTG Buy
- PRTA Buy
- Analyst Count
- PNTG 6
- PRTA 9
- Target Price
- PNTG $35.17
- PRTA $27.67
- AVG Volume (30 Days)
- PNTG 291.3K
- PRTA 1.7M
- Earning Date
- PNTG 08-05-2025
- PRTA 08-07-2025
- Dividend Yield
- PNTG N/A
- PRTA N/A
- EPS Growth
- PNTG 40.99
- PRTA N/A
- EPS
- PNTG 0.76
- PRTA N/A
- Revenue
- PNTG $748,167,000.00
- PRTA $137,935,000.00
- Revenue This Year
- PNTG $25.01
- PRTA N/A
- Revenue Next Year
- PNTG $8.19
- PRTA $119.20
- P/E Ratio
- PNTG $34.40
- PRTA N/A
- Revenue Growth
- PNTG 30.04
- PRTA 54.55
- 52 Week Low
- PNTG $21.18
- PRTA $4.32
- 52 Week High
- PNTG $37.13
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- PNTG 37.30
- PRTA 59.96
- Support Level
- PNTG $25.53
- PRTA $5.96
- Resistance Level
- PNTG $26.53
- PRTA $6.59
- Average True Range (ATR)
- PNTG 1.07
- PRTA 0.38
- MACD
- PNTG -0.36
- PRTA 0.15
- Stochastic Oscillator
- PNTG 11.51
- PRTA 83.93
About PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).